These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24930886)

  • 1. KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation.
    Ikenberg K; Valtcheva N; Brandt S; Zhong Q; Wong CE; Noske A; Rechsteiner M; Rueschoff JH; Caduff R; Dellas A; Obermann E; Fink D; Fuchs T; Krek W; Moch H; Frew IJ; Wild PJ
    J Pathol; 2014 Oct; 234(2):239-52. PubMed ID: 24930886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.
    Noetzel E; Rose M; Bornemann J; Gajewski M; Knüchel R; Dahl E
    Oncogene; 2012 Apr; 31(16):2101-14. PubMed ID: 21909132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
    Zhang X; Kyo S; Nakamura M; Mizumoto Y; Maida Y; Bono Y; Takakura M; Fujiwara H
    Cancer Lett; 2014 Apr; 345(1):106-14. PubMed ID: 24333732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.
    Wik E; Birkeland E; Trovik J; Werner HM; Hoivik EA; Mjos S; Krakstad C; Kusonmano K; Mauland K; Stefansson IM; Holst F; Petersen K; Oyan AM; Simon R; Kalland KH; Ricketts W; Akslen LA; Salvesen HB
    Clin Cancer Res; 2013 May; 19(9):2331-41. PubMed ID: 23538402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
    Lu Y; Xiao L; Liu Y; Wang H; Li H; Zhou Q; Pan J; Lei B; Huang A; Qi S
    Autophagy; 2015; 11(12):2213-32. PubMed ID: 26553592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer.
    Nakamura M; Kyo S; Zhang B; Zhang X; Mizumoto Y; Takakura M; Maida Y; Mori N; Hashimoto M; Ohno S; Inoue M
    Hum Pathol; 2010 Nov; 41(11):1516-29. PubMed ID: 20800872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
    Salvesen HB; Das S; Akslen LA
    Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
    Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
    Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E-Cadherin expression vs. tumor cell proliferation paradox in endometrial cancer.
    González-Rodilla I; Aller L; Llorca J; Muñoz AB; Verna V; Estévez J; Schneider J
    Anticancer Res; 2013 Nov; 33(11):5091-5. PubMed ID: 24222154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
    Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
    Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
    Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
    Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
    Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
    Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.